DeepMed Research

Poitiers University Hospital

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Established: 1961-01-01

Employees: 5K

Market Cap: -

Website: https://www.chu-poitiers.fr

Clinical Trials

Interest of Treatment of Obstructive Sleep Apnea Syndrome by Constant CPAP and Auto CPAP

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea Syndromes

Interventions: Device: Constant Continuous Positive Airway Pressure
Device: Automatic continuous Positive Airway Pressure

First Posted Date: 2016-04-25

Last Posted Date: 2016-04-25

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 800

Registration Number: NCT02749812

Effects of Sleep Deprivation on Diaphragm Command During an Inspiratory Endurance Trial in Healthy Volunteers.

Not Applicable

Completed

Conditions: Healthy Volunteers
Sleep Deprivation
Diaphragm

Interventions: Behavioral: Normal sleep night
Behavioral: Sleepless night

First Posted Date: 2016-03-31

Last Posted Date: 2017-12-11

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 20

Registration Number: NCT02725190

Locations: 🇫🇷
CHU de Poitiers, Poitiers, France

Comparative Noninvasive Continuous Cardiac Output by the Clearsight With Invasive Monitoring by Pulsioflex in Abdominal Surgery

Not Applicable

Completed

Conditions: Cardiac Output Measurement

First Posted Date: 2016-03-23

Last Posted Date: 2018-05-18

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 30

Registration Number: NCT02717468

Locations: 🇫🇷
Matthieu BOISSON, Poitiers, France

Study of Repeated Cefoxitin Administration in Major Abdominal Surgery Using a Microdialysis Technique

Phase 4

Completed

Conditions: Antibiotic Prophylaxis Surgery

First Posted Date: 2016-03-09

Last Posted Date: 2017-06-12

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 12

Registration Number: NCT02703857

Locations: 🇫🇷
Centre Hospitalier de Poitiers, Poitiers, France

Validation of a Diagnostic Algorithm of Giant Cell Arteritis

Not Applicable

Completed

Conditions: Giant Cell Arteritis

Interventions: Other: color Doppler ultrasound and TAB in case of CDU negative

First Posted Date: 2016-03-09

Last Posted Date: 2024-12-13

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 165

Registration Number: NCT02703922

Locations: 🇫🇷
Centre Hospitalier d'Angoulême, Angoulême, France
🇫🇷
Centre Hospitalier Universitaire de Nantes, Nantes, France
🇫🇷
Groupe Hospitalier de la Rochelle Ré Aunis, La Rochelle, France

and more 3 locations

Comparison of Pre-oxygenation of NIV and HFNC Therapy for Intubation of ICU Patients With Acute Respiratory Failure

Not Applicable

Completed

Conditions: Acute Respiratory Failure
Intratracheal Intubation

Interventions: Procedure: High Flow nasal canula oxygen therapy
Procedure: Noninvasive ventilation

First Posted Date: 2016-01-29

Last Posted Date: 2017-10-11

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 320

Registration Number: NCT02668458

Locations: 🇫🇷
CHU louis MOURIER, Colombes, France
🇫🇷
CHU La cavale Blanche, Brest, France
🇫🇷
Chu Mondor, Creteil, France

and more 24 locations

Medico-Economic Analysis of Management of Flail Chest Between Medical Treatment and Surgical Treatment With Stracos

Not Applicable

Conditions: Polytraumatises With Rib Fractures

Interventions: Device: Thoracic osteosyntheses with Stracos

First Posted Date: 2015-12-18

Last Posted Date: 2019-04-08

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 310

Registration Number: NCT02635165

Locations: 🇫🇷
Hospital University of Poitiers, Poitiers, France

Resveratrol for Exudative Age-Related Macular Degeneration

Not Applicable

Terminated

Conditions: Choroidal Neovascularisation
Age-related Macular Degeneration
AMD

Interventions: Dietary Supplement: Resvega
Dietary Supplement: Trans-Resveratrol
Dietary Supplement: placebo

First Posted Date: 2015-12-09

Last Posted Date: 2020-06-01

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 25

Registration Number: NCT02625376

Locations: 🇫🇷
CHU de Poitiers - Ophtalmology, Poitiers, France

Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients

Phase 2

Completed

Conditions: Morbid Obesity

Interventions: Drug: Sugammadex 4 mg/kg
Drug: Sugammadex 1 mg/kg
Drug: Sugammadex 2 mg/kg

First Posted Date: 2015-09-10

Last Posted Date: 2016-10-12

Lead Sponsor: Poitiers University Hospital

Registration Number: NCT02545595

Locations: 🇫🇷
CHU de Poitiers, Poitiers, France

Impact of the Addition of a Device Providing Continuous Pneumatic Regulation of Tube Cuff Pressure to an Overall Strategy Aimed at Preventing Ventilator-associated Pneumonia in the Severe Trauma Patient. A Multicentre, Randomised, Controlled Study.

Not Applicable

Completed

Conditions: Ventilation-associated Pneumonia
Severe Trauma Patient

First Posted Date: 2015-08-28

Last Posted Date: 2019-04-25

Lead Sponsor: Poitiers University Hospital

Target Recruit Count: 440

Registration Number: NCT02534974

Locations: 🇫🇷
Belaid BOUHEMAD, Dijon, France
🇫🇷
Sébastien PILI FLOURY, Besançon, France
🇫🇷
Sigismond LASOCKI, Angers, France

and more 10 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy